Celldex Therapeutics reported $163K in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Agenus AGEN:US $ 20.93M 5.01M
Amgen AMGN:US $ 6594M 356M
Applied Genetic Technologies AGTC:US $ 0.32M 0.32M
Biocept BIOC:US $ 19.94M 5.97M
Bristol Myers Squibb BMY:US $ 11887M 239M
Celldex Therapeutics CLDX:US $ 0.16M 0.01M
Cytrx CYTR:US 0 0
Glaxosmithkline GSK:US $ 6929M 2851M
Immunogen IMGN:US $ 14.16M 23.92M
Nektar Therapeutics NKTR:US $ 21.58M 3.24M
Newlink Genetics NLNK:US $ 0.4M 0.29M
Northwest Biotherapeutics NWBO:US 477K 74K
Pfizer PFE:US $ 27742M 2081M
Rigel Pharmaceuticals RIGL:US $ 29.82M 13.08M
Roche Holding ROG:VX 16.44B 474M
Seattle Genetics SGEN:US $ 497.5M 71.04M